Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Deferasirox, sold under the brand name Exjade among others, is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved in the United States for this purpose.
Read the full article on WikipediaChronic iron overload Clinical criteria: Treatment Phase: Initial treatment Patient must be red blood cell transfusion dependent, AND Patient must have a serum ferritin level of greater than 1000 microgram/L, AND Patient must have a malignant disorder of haemopoiesis, AND Patient must have a median life expectancy exceeding five years.
“8 to 16 hours”
Working under the parallel aged-care framework? Aged-care equivalent →